We tested 53 fixed duodenal biopsy samples from 25 patients with Whipple disease for the presence Giardia and 6 fresh duodenal biopsy samples for Giardia duodenalis DNA by polymerase chain reaction (PCR). We also used histological examination and PCR assay to determine the prevalence of G. duodenalis in duodenal biopsy samples from 150 control patients without Whipple disease. Three of 25 patients with Whipple disease had histological evidence of giardiasis, whereas only 1 of 150 control patients was affected ( ). By PCR, P ! .001 we found Giardia in 2 of 6 patients with Whipple disease whom we tested, but in only 2 of 150 control patients ( ). In a literature review, we identified 15 other cases of coinfection. The occurrence of these P ! .001 diseases may be promoted by a common immune defect or a common source of infection, or infection with one may predispose to infection with the other.
Whipple disease occurs worldwide and is a chronic systemic illness caused by the bacterium Tropheryma whipplei [1] [2] [3] [4] . It is characterized by arthralgia and diarrhea, but the clinical presentation may vary significantly from patient to patient, and the organism has been found in patients without gastrointestinal symptoms [1, 3, 4] . When the disease develops, it is fatal unless specific antibiotic therapy is administered. The standard method of diagnosis is histological examination of duodenal biopsy samples in which periodic acid-Schiff (PAS)-positive, diastase-resistant organisms are observed in macrophages [1] [2] [3] [4] . Advancement in molecular technologies and the recent isolation and culture of the bacterium promise new perspectives for diagnosis [5] [6] [7] [8] . Whipple disease is diagnosed infrequently, although some preliminary studies have found that T. whipplei DNA is frequently detected in healthy people and in the environment [9] [10] [11] . However, these findings have not been reproduced by others [12, 13] . The pathogenesis of Whipple disease is poorly understood, but it has been hypothesized that the disease occurs only in patients who have particular risk factors or that only specific strains of T. whipplei cause the disease [1] [2] [3] [4] .
Giardiasis is an infection caused by the flagellated protozoan Giardia duodenalis (syn Giardia intestinalis and Giardia lamblia). It occurs worldwide, but its prevalence is low in developed countries and high in developing countries. The disease varies in presentation from a subclinical carrier state (∼60% of infected persons) to a severe malabsorption syndrome [14] [15] [16] . Several explanations have been offered for the broad range of signs; these include variability in the virulence of different strains of the organism, inoculum size, and the state of the host's immune system [14] [15] [16] [17] . Giardiasis is usually diagnosed by the direct identification of trophozoites or cysts in stool specimens [16] . The disease can also be diagnosed using immunoassays, especially ELISAs for G. duodenalis antigen in fecal specimens [16] . Sometimes, however, the results of stool examinations are repeatedly negative, especially in patients with chronic disease [16] . In these cases, the histological examination of duodenal biopsy samples is useful in establishing a diagnosis [16] .
The successful culture of T. whipplei in our laboratory has enabled us to further investigate patients with Whipple disease. We found 2 patients from the Marseille area who had concurrent giardiasis and Whipple disease; we therefore decided to establish the prevalence of giardiasis in 25 patients with Whipple disease from whom we had obtained duodenal samples. We also investigated the prevalence of giardiasis in duodenal bi-opsy samples from control patients with no evidence of Whipple disease. A review of the current literature was also done, to find other reports of coinfection.
PATIENTS, MATERIALS, AND METHODS
Patients and control subjects. Our laboratory has offered a diagnostic test for Whipple disease since 2000. From our records, we selected 25 patients with Whipple disease that had been diagnosed on the basis of clinical features, histological findings, and polymerase chain reaction (PCR) studies of duodenal biopsy samples [13] . Electron microscopy was not done on any samples. For each patient, a standardized questionnaire, including epidemiological and clinical features, had been completed by the physician in charge. Fifty-three paraffin-embedded duodenal biopsy samples from the 25 patients were available for further histological studies. Five biopsy samples from 5 patients had been obtained prior to the patients having been diagnosed with Whipple disease. Twenty-three follow-up biopsy samples were available from 8 patients at various times during therapy. Six fresh duodenal biopsy samples, obtained from 6 patients before therapy was initiated, were available for PCR studies.
The control group was composed of 150 patients (80 men and 70 women; mean age, 50 years) who had had duodenal biopsy samples obtained by endoscopy, for another reason, in the same hospital in Marseille, France. None of the control patients had Whipple disease, as determined by histological and PCR results [13] . The ethical committee approved the study, and all patients gave informed consent for their specimens to be tested for research purposes.
Histological studies. Sections of 4 mm in size were cut from formalin-fixed, paraffin-embedded biopsy samples and were stained with routine hematoxylin-phoxine-saffron (HPS). For each tissue specimen, serial sections were also obtained for diastase-digested PAS staining and immunohistochemical investigations using a polyclonal antibody to T. whipplei, as described elsewhere [7] . The slides stained with HPS were also examined for Giardia organisms. The diagnosis of giardiasis was made when the characteristic morphology of the microorganisms-a pearlike shape and double nuclei-were observed.
PCR amplification and sequencing. DNA was extracted from duodenal biopsy samples with the QIAamp Tissue Kit (Qiagen), according to the manufacturer's instructions [7] . For T. whipplei PCR, the 16S-23S rDNA intergenic spacer region was amplified and sequenced using the primers tw3f and tw4r, and domain III of the 23S rRNA gene was amplified and sequenced using the primers TW-23InsF and TW-23InsR2, as described elsewhere [18, 19] . For G. duodenalis PCR, a 218-bp region of the b giardin gene of Giardia was amplified by PCR that incorporated primers GGL 405-433 (5 -CAT AAG GAC GCC ATC GCG GCT CTC AGG AA-3 ) and GGR 599-622 (5 -TTT GTG AGC GCT TCT GTC GTG GCA GCG CTA A-3 ) (Eurogentec) [20] . A negative biopsy control was included in each experiment for every 7 samples. A total of 2.5 mL of the extracted DNA was amplified in a 25-mL reaction mixture that contained 12.5 pmol of each primer (dATP, dCTP, dGTP, and dTTP), each at a concentration of 200 mmol/L, and 1 U of Elongase in 1ϫ PCR buffer with 0.8 mL of 25 mmol/L MgCl 2 (Life Technologies). PCRs were done in a Peltier Thermal Cycler PTC-200 (MJ Research) under the following conditions: an initial 3-min denaturation step at 94ЊC was followed by a total of 40 cycles of denaturation at 94ЊC (for 30 s), annealing at 60ЊC (for 30 s), and extension at 72ЊC (for 1 min). Amplification was completed by holding the reaction mixture for 3 min at 68ЊC, to allow the complete extension of the PCR products. PCR products were detected using ethidium-bromidestained 1% agarose gel electrophoresis analysis. Amplicons purified using Qiagen columns (QIAquick Spin PCR purification kit; QIAGEN) were sequenced using the dRhodamine Terminator cycle-sequencing ready reaction kit (PE Applied Biosystems), according to the manufacturer's recommendations. Sequences were aligned with sequences in the GenBank DNA sequence database with the program BLAST (version 2.0; National Center for Biotechnology Information).
Statistical analysis. We compared the number of patients who had Whipple disease and giardiasis with the number of people with giardiasis in the control group using Fisher's exact test in Epi Info (version 6.04a; Centers for Disease Control and Prevention). was considered to be statistically different. P ! .05 Review of the literature. A MEDLINE search for reports published from 1966 through 2001 was done using the keywords "T. whippelii," "T. whipplei," "Whipple disease," "G. duodenalis," "G. intestinalis," "G. lamblia," and "Giardiasis." We also consulted Dobbins's review book, collecting information on all identified cases of Whipple disease before 1986 [21] . We identified additional cases from these reports by cross-referencing. All the case reports were read, whatever the language.
RESULTS
Patients with Whipple disease. Four of 25 patients diagnosed with Whipple disease also had giardiasis, according to the results of histological (3/25) or genomic (2/6) studies. The clinical features, diagnosis, treatment, and outcome for patients with the concurrent infections are presented in table 1.
Pathological findings and immunological detection. In patient 1 (table 1), the histological examination of biopsy specimens revealed large and foamy macrophages in the lamina propria of the intestinal mucosa ( figure 1, top) . These macrophages contained numerous intracytoplasmic granules that were positive on PAS staining and were resistant to diastase. Other histological changes were observed, such as dilated lym- phatic channels and flattened villi. Trophozoites of G. duodenalis were seen immediately adjacent to the duodenal surface epithelium ( figure 1, top) . These microorganisms have a characteristic morphology-a pearlike shape and double nuclei. According to the results of immunohistological testing, T. whipplei bacilli were seen as coarse, granular, immunopositive material in the macrophage cytoplasm ( figure 1, bottom) . The G. duodenalis organisms were immunonegative to the anti-T. whipplei antibody ( figure 1, bottom) . In patient 2 ( Comparisons between patients with Whipple disease and those in the control group. One of 150 patients without Whipple disease had Giardia that were detected by histological examination. This prevalence of infection (0.6%) was significantly lower than that in the Whipple disease group (3/25) ( ). Two (of 150) patients without Whipple disease tested P ! .001 positive by PCR for Giardia, and this prevalence was also significantly lower ( ) than that in the patients with Whip-P ! .001 ple disease (2/6). Using the results of all diagnostic tests, 2 patients without Whipple disease were infected with Giardia, which is significantly fewer ( ) than was the case with P ! .001 the group with Whipple disease (4/25). Of the 2 patients with Whipple disease and the 2 patients from the control group who had a diagnosis of giardiasis and for whom both techniques could be done, 2 were positive by histological testing and 4 by PCR (no significant difference, ). P p .21 Review of the literature. A review of the literature enabled us to identify 15 other patients with coinfections [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . In 1991, when reporting on a male patient with Whipple disease and giardiasis in the American Journal of Medicine, Bassoti et al. [25] stressed that, to the best of their knowledge, theirs was the first report of coinfection. Subsequent letters to the editor [34, 35] revealed that 3 cases of coinfection had previously been reported. In our search, we found there were, in fact, 4 reports made before 1991 [26, 29, 31] , including 3 descriptions that were published in non-English language journals and were not indexed in all literature databases. These cases were not, then, readily available to an international audience; in a literature review in 1987, Dobbins found only 3 of these reports [21] . Of all reports of coinfection, half have been published in languages other than English. We have summarized the reported findings of these 15 patients in table 1. Giardiasis was diagnosed mainly by the presence of Giardia trophozoites in duodenal biopsy samples, but, in 3 patients, the diagnosis was based on finding Giardia cysts in stool samples. In most patients, the major clinical signs were diarrhea and arthralgia. One patient (patient 17) had weight loss, and Whipple disease endocarditis was diagnosed by histopathological testing of the heart valve; a duodenal biopsy sample revealed the presence of Giardia. The duodenal biopsy sample was negative for PAS-positive macrophages on histological examination and was also negative for T. whipplei DNA by PCR testing [22] . In 1996, while reinvestigating the small-bowel histological testing of a series of 48 patients with Whipple disease, von Herbay et al. [23] found 4 patients with G. duodenalis trophozoites adjacent to the villous surface (8.3%), which is 2 more than had been reported originally in the same group of patients.
DISCUSSION
The prevalence of Giardiasis is 2%-5% in industrialized countries [16] . In our study, 4 (16%) of 25 patients with Whipple disease had concurrent giardiasis as diagnosed by histological testing and PCR. The prevalence of giardiasis in the patients with Whipple disease was statistically significantly higher than that in the control group of patients without Whipple disease. This association between intestinal Whipple disease and giardiasis may not be incidental. The diagnosis of giardiasis is often difficult; many diagnoses are missed by the standard series of 3 stool examinations [14] . Some patients with chronic diarrhea and malabsorption may have repeatedly negative results of stool examinations. The direct examination of duodenal fluid may be useful [14, 16] . When giardiasis is not confirmed by the above methods, it can be diagnosed by the histopathological testing of duodenal biopsy samples, which also enables the detection of other diseases that cause diarrhea and malabsorption, such as Whipple disease, other protozoan parasites, and lymphoma. Usually, imprint smears are prepared from the biopsy samples before they are submitted for routine histological examination. The sensitivity of histopathological testing in the diagnosis of giardiasis is higher than that of stool microscopy [14] , but false-negative results may still occur. This is because G. duodenalis is a small organism and, hence, is difficult to find. Also, during preparation for histological testing, its morphology may be considerably distorted [14] , and organisms may be lost from the lumenal surface of sections. There are few data on the use of PCR to diagnose giardiasis [36, 37] . Studies have only been done on stool samples, and reported sensitivities have varied, probably because of the presence of PCR inhibitors in fecal samples [36, 37] . In our study, we used a PCR-based assay targeting the giardin gene to detect G. duo-denalis DNA in duodenal biopsy samples [20] . This technique enabled us to diagnose giardiasis more frequently (4/4) than by the histological examination of duodenal biopsy samples (2/4), although the difference was not statistically significant. Our first results are promising and indicate that PCR may be a useful tool to use on duodenal biopsy samples for the diagnosis of giardiasis.
The association we found between the occurrence of Whipple disease and giardiasis may be due to a common host factor or to a common source of infection, or one disease may predispose to the other. To date, no common host factor has been associated with these 2 diseases. Several immunological abnormalities have been reported during active Whipple disease, but the data do not allow generalizations [38] . Controversial evidence has been presented that the prevalence of the HLA-B27 genotype is higher in patients with Whipple disease [39] . T. whipplei infections have been reported in 3 patients with AIDS [40] [41] [42] . Patients with AIDS do not seem then to be more frequently infected with T. whipplei than other persons. Defects in the complement system of immunity have been described prior to, during, and for many years after the treatment of Whipple disease [43] . Reduced interleukin-12 and interferon-g production by peripheral blood mononuclear cells has been detected in patients and relatives of patients with Whipple disease [44] . Hypogammaglobulinemia has occasionally been described in patients with Whipple disease [44] . The host factors that may underlie giardiasis are poorly understood [15] . Studies have reported that the prevalence of Giardia cysts in the stools of people with congenital and acquired hypogammaglobulinemia is significantly higher than it is in immunocompetent patients [45] [46] [47] [48] [49] [50] . Patients with AIDS do not seem to be more frequently infected with Giardia than healthy persons [51] . However, the large time interval (2 years) between a diagnosis of Whipple disease and that of Giardia observed in our study for 2 patients could indicate a role of host factors in the development of Whipple disease and giardiasis, but this common host factor has not yet been determined.
A common source of infection may be responsible for concurrent disease, given that the 2 microorganisms seem to be present in natural habitats, such as water and soil [11, 16] . Both pathogens have been found in sewage treatment plants [11, 52] , and both have been found in a single stool specimen by PCR [3, 36, 37] . There may then be a common oral-fecal route of infection for both diseases, and it might be possible for Giardia to carry T. whipplei, as has been described for an amoeba carrying Legionella pneumophila and the fungus Cryptococcus neoformans [52, 53] . Amoebae act as a vehicle or "Trojan horse" for the latter microorganisms, enabling their survival and spread in the natural environment and concurrent infections in people [52, 53] . Other protozoa, such as Giardia, might play a similar role by providing a protozoan intracellular niche that protects and disseminates T. whipplei [54] . However, Giardia is not a phagocytic protozoan, and there is no current knowledge that it may harbor bacteria. Also, that we have not found evidence with our T. whipplei antibody that Giardia harbored Whipple bacillus is not in favor of this hypothesis. The hypothesis that one disease predisposes people to develop the other could should also be further explored, because Giardia and T. whipplei distort the villous architecture, which may result in a defect in the local defense mechanisms of the host. A recent study described the invasion and destruction of predominantly IgA-type mucosal plasma cells by T. whipplei [55] . This may lead to a locally diminished secretory IgA response, which could be a predisposing factor for Giardia infection. A defect in secretory IgA has been suspected to affect the elimination of G. duodenalis from the gut, but the available evidence is inconclusive [56, 57] . The presence of dilated lymphatic channels, flattened villi, and abnormal phagocytic capacity of macrophages in Whipple disease may also favor infection by G. duodenalis [58] .
In conclusion, our study has revealed a significant association between concurrent infections with T. whipplei and G. duodenalis. Different treatments are required for each infection, so it is important that physicians look for giardiasis in patients with Whipple disease and vice versa. In particular, the possibility of concurrent Whipple disease should be investigated in all patients with relapsing or chronic giardiasis.
